# A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

> **NCT06867094** · PHASE2 · RECRUITING · sponsor: **Sanofi** · enrollment: 204 (estimated)

## Conditions studied

- Colitis Ulcerative

## Interventions

- **DRUG:** SAR441566
- **DRUG:** SAR441566 matching Placebo

## Key facts

- **NCT ID:** NCT06867094
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-28
- **Primary completion:** 2027-07-29
- **Final completion:** 2028-05-11
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06867094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06867094, "A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06867094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*